Skip to main content

Advertisement

Figure 2 | Diagnostic Pathology

Figure 2

From: Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy

Figure 2

Biochemical recurrence (BCR)-free survival curves for two groups defined by low and high expression of miR-126 in patients with PCa. The patients with low miR-126 expression had significantly shorter BCR-free survival after radical prostatectomy than patients with high miR-126 expression did (P < 0.001).

Back to article page